Vice President Ann Baker will moderate a session entitled “Covering all the bases: An integrated approach to strategic drug development.” John Cole will facilitate BIO-Europe’s Academic Innovators track, a series of presentations designed to bridge the gap and encourage collaboration between academia and the biopharma industry.
CRA is a silver sponsor and exhibitor for this annual conference. Visit us at booth #27.
For more information on this event, click here.
Biosimilars: Economic Issues for IP Litigation
In July 2021, the U.S. Food and Drug Administration granted a determination of interchangeability to a biosimilar drug for the first time. This approval has...